Wayne biotech firm received $67.5 million investment to test gene therapy for heart disease
The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...
Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer
Previously at MeiraGTx, GSK and Novartis, Dr. Leighton will help Chemify scale the company’s operational capacity to meet ...
'Discordant Dots': Why Phila. Zantac Judge Rejected Bid for His Recusal
In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
Spero Therapeutics Faces SEC Probe and Leadership Changes
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
EurekAlert!2d
CCM Biosciences scientists report discovery of first-in-class longevity therapeutics
Compounds that enhance enzyme activity show promise for cellular rejuvenation and treating age-related diseases. However, ...
Becker's Hospital Review1d
FDA mandates warnings for 2 RSV vaccines
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Moderna stock on track for 20% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
GSK marks century in India with commemorative ₹5 stamp
Drugmaker GSK said, a stamp has been released by India Post to commemorate its 100 years in India. The ₹5 denomination stamp ...
Global Severe Asthma Treatment Market Poised For Significant Growth To Reach USD 36.18 Billion By 2033: FMI Study
North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.